A patient had undergone left pneumonectomy for lung cancer and had an increased risk of fatal complications such as pneumonia, including acute respiratory distress syndrome (ARDS). The treatment effects of veno-venous extracorporeal membrane oxygenation (VV-ECMO) for ARDS of postpneumonectomy patient are uncertain. A 74-year-old man with one lung experienced aspiration pneumonia while swallowing pills after the operation, and his condition progressed to ARDS within a day. He was successfully treated with VV-ECMO support and intensive care unit care.
sleeping because of insomnia. That night, the pills stuck in his throat. Hence, he drank water, following which he complained of cough and severe dyspnea. Chest radiography showed diffuse opacity in the right lung (Fig. 1A) , and oxygen saturation (SaO 2 ) level dropped to 82%. He was transferred to the ICU immediately. Subsequently, endotracheal intubation was performed and a ventilator with volume control mode was used to maintain the inspired oxygen fraction (FiO 2 ) at 100%. The tidal volume was 300 mL, positive end-expiratory pressure (PEEP) was 7 cmH 2 O and respiratory rate (RR) was 30. After initiation of mechanical ventilation, the SaO 2 level of arterial blood gas increased to 93%.
On hospital day (HD) 2, the patient was more stable than on the previous day. FiO 2 showed aggravation of diffuse opacity and infiltration in the whole right lung (Fig. 1B) , and the results of the arterial blood gas analysis (ABGA) showed hypoxemia with severe hypercapnic respiratory acidosis ( Table 1 .
Although PaCO 2 was high, the patient did not complain of dyspnea. The white blood cell count was 9,800/μL (75.1% neutrophil segment) and CRP level was 20.98 mg/L. On HD 60, the patient was transferred to the general ward. The brief course of the patient's condition is shown in Fig. 2 .
Discussion
If cases of severe hypoxemia and hypercapnic acidemia do not improve with conventional mechanical ventilator support, ECMO can be used for life support. [3] VV-ECMO is recommended for isolated lung failure without cardiac failure. This technique, which allows optimal gas exchange, has gained consensus as a supportive treatment when conventional mechanical ventilation fails. [5] Nevertheless, VV-ECMO is a procedure associated with high costs and resource utilization. [6] VV-ECMO use should be carefully determined for high-risk patients.
In this case, the patient was >70 years old and had un- and 31 -years -old, respectively. [7, 8] Pneumonectomy results in pulmonary function deficits and decreases exercise capacity. [9, 10] Forced vital capacity, forced expiratory volume in 1 s, and diffusion capacity for carbon monoxide are all reduced postsurgery, with a more significant decline. [9, 10] Most reports showed that postpneumonectomy patients have diminished exercise tolerance due to mechanical respiratory limitation, low ventilator capacity, reduced breathing reserve, and dyspnea without significant differences between right or left lung removal. [11] [12] [13] [14] [15] The regimens were inappropriate, and pneumonia might be aggravated. The antibiotics were changed to ceftriaxone and clindamycin to treat Pseudomonas in the sputum after the infecting bacteria were identified. After 2 weeks, the patient had fever and the haziness of the right lung was enhanced.
The medication was changed to meropenem and ampicillin/ sulbactam to treat multi-drug resistant Acinetobacter baumannii.
In conclusion, the medical team could consider ECMO to treat aspiration pneumonia in postpneumonectomy patients or other high-risk patients. Once aspiration pneumonia occurs, the respiratory system can develop pneumonitis, pneumonia, and acute lung injury, including ARDS. If severe hypoxemia and hypercapnia occurs and optimal gas exchange cannot achieved by conventional mechanical ventilation, extracorporeal life support can have survival benefits even in postpneumonectomy.
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